René Rückert
Direttore operativo presso Isarna Therapeutics GmbH
Posizioni attive di René Rückert
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Direttore operativo | 01/01/2019 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2018 | 01/01/2019 |
Storia della carriera di René Rückert
Formazione di René Rückert
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Warwick Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Germania | 3 |
| Regno Unito | 2 |
Posizioni
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- René Rückert
- Esperienza
